nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—Peptide GPCRs—CCR3—atopic dermatitis	0.00925	0.0384	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CXCR3—atopic dermatitis	0.00809	0.0336	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR3—atopic dermatitis	0.00619	0.0257	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00556	0.0231	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—NPS—atopic dermatitis	0.00546	0.0226	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CXCR3—atopic dermatitis	0.00541	0.0225	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR5—atopic dermatitis	0.00507	0.021	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00495	0.0206	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CXCR3—atopic dermatitis	0.00459	0.019	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00444	0.0184	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL22—atopic dermatitis	0.00423	0.0176	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL27—atopic dermatitis	0.00377	0.0157	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00372	0.0154	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00358	0.0149	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00341	0.0141	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR5—atopic dermatitis	0.00339	0.0141	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL17—atopic dermatitis	0.00338	0.014	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00332	0.0138	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00298	0.0124	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00297	0.0123	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00292	0.0121	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CCR5—atopic dermatitis	0.00288	0.0119	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL22—atopic dermatitis	0.00283	0.0118	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL11—atopic dermatitis	0.00273	0.0113	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—NPS—atopic dermatitis	0.00263	0.0109	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00263	0.0109	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.0026	0.0108	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.0026	0.0108	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00255	0.0106	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL27—atopic dermatitis	0.00253	0.0105	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.0024	0.00995	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00235	0.00976	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00235	0.00976	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL17—atopic dermatitis	0.00226	0.0094	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR3—atopic dermatitis	0.00222	0.00922	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL22—atopic dermatitis	0.00217	0.00901	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCL27—atopic dermatitis	0.00213	0.00884	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00206	0.00856	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—TAC1—atopic dermatitis	0.00198	0.00822	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—NPS—atopic dermatitis	0.00198	0.00822	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00195	0.00811	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCR3—atopic dermatitis	0.00194	0.00806	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL27—atopic dermatitis	0.00194	0.00803	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00187	0.00775	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL11—atopic dermatitis	0.00183	0.00758	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00178	0.00737	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00174	0.00723	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00174	0.00723	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL17—atopic dermatitis	0.00174	0.0072	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00171	0.00709	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.0016	0.00664	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL10—atopic dermatitis	0.00157	0.00652	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR3—atopic dermatitis	0.00149	0.00618	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL22—atopic dermatitis	0.00145	0.00603	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL27—atopic dermatitis	0.00143	0.00592	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL11—atopic dermatitis	0.0014	0.00581	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00138	0.00573	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FCER2—atopic dermatitis	0.00138	0.00573	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL5—atopic dermatitis	0.00135	0.00561	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—TAC1—atopic dermatitis	0.00133	0.0055	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—NPS—atopic dermatitis	0.00133	0.0055	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCR3—atopic dermatitis	0.0013	0.0054	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL27—atopic dermatitis	0.0013	0.00538	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL22—atopic dermatitis	0.00128	0.00532	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR3—atopic dermatitis	0.00126	0.00521	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR5—atopic dermatitis	0.00122	0.00505	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00119	0.00493	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL17—atopic dermatitis	0.00116	0.00482	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL27—atopic dermatitis	0.00114	0.00474	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR3—atopic dermatitis	0.00114	0.00473	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—NPS—atopic dermatitis	0.00112	0.00465	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—TAC1—atopic dermatitis	0.00112	0.00465	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.0011	0.00456	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00107	0.00444	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL10—atopic dermatitis	0.00105	0.00436	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL5—atopic dermatitis	0.00104	0.00432	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL17—atopic dermatitis	0.00103	0.00426	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—TAC1—atopic dermatitis	0.00102	0.00422	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—NPS—atopic dermatitis	0.00102	0.00422	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000997	0.00414	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000967	0.00401	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL5—atopic dermatitis	0.000945	0.00392	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL11—atopic dermatitis	0.000937	0.00389	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FCER2—atopic dermatitis	0.000924	0.00383	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KIF3A—atopic dermatitis	0.000914	0.00379	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL5—atopic dermatitis	0.000905	0.00376	CbGpPWpGaD
Goserelin—LHCGR—neck—atopic dermatitis	0.000894	0.786	CbGeAlD
Goserelin—LHCGR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000888	0.00368	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL22—atopic dermatitis	0.000859	0.00356	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000841	0.00349	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CMA1—atopic dermatitis	0.000827	0.00343	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL11—atopic dermatitis	0.000827	0.00343	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR5—atopic dermatitis	0.000815	0.00338	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000806	0.00334	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT6—atopic dermatitis	0.000777	0.00323	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL27—atopic dermatitis	0.000765	0.00318	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000764	0.00317	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR3—atopic dermatitis	0.000764	0.00317	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—NPS—atopic dermatitis	0.00075	0.00311	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—TAC1—atopic dermatitis	0.00075	0.00311	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000736	0.00306	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000735	0.00305	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL5—atopic dermatitis	0.000697	0.00289	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL5—atopic dermatitis	0.000694	0.00288	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000688	0.00286	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL17—atopic dermatitis	0.000687	0.00285	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NPS—atopic dermatitis	0.000681	0.00282	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—TAC1—atopic dermatitis	0.000681	0.00282	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR3—atopic dermatitis	0.000674	0.0028	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000668	0.00277	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000647	0.00269	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL5—atopic dermatitis	0.000633	0.00263	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR5—atopic dermatitis	0.000625	0.00259	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KIF3A—atopic dermatitis	0.000612	0.00254	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TAC1—atopic dermatitis	0.000601	0.00249	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NPS—atopic dermatitis	0.000601	0.00249	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000594	0.00247	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCR3—atopic dermatitis	0.000589	0.00244	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL5—atopic dermatitis	0.000558	0.00232	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CMA1—atopic dermatitis	0.000553	0.0023	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL11—atopic dermatitis	0.000553	0.0023	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL10—atopic dermatitis	0.00054	0.00224	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT6—atopic dermatitis	0.00052	0.00216	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000511	0.00212	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000493	0.00205	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000491	0.00204	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL10—atopic dermatitis	0.000476	0.00198	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL5—atopic dermatitis	0.000464	0.00193	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000461	0.00191	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR3—atopic dermatitis	0.000451	0.00187	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR5—atopic dermatitis	0.000418	0.00174	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000416	0.00173	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL5—atopic dermatitis	0.00041	0.0017	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TAC1—atopic dermatitis	0.000402	0.00167	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NPS—atopic dermatitis	0.000402	0.00167	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2—atopic dermatitis	0.000398	0.00165	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR3—atopic dermatitis	0.000394	0.00164	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NGF—atopic dermatitis	0.00038	0.00158	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000378	0.00157	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL5—atopic dermatitis	0.000374	0.00155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR5—atopic dermatitis	0.000369	0.00153	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—atopic dermatitis	0.000361	0.0015	CbGpPWpGaD
Goserelin—Malaise—Triamcinolone—atopic dermatitis	0.000329	0.000434	CcSEcCtD
Goserelin—Anxiety—Hydrocortisone—atopic dermatitis	0.000329	0.000434	CcSEcCtD
Goserelin—Malaise—Methylprednisolone—atopic dermatitis	0.000328	0.000433	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000328	0.000432	CcSEcCtD
Goserelin—Discomfort—Hydrocortisone—atopic dermatitis	0.000326	0.00043	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000324	0.000427	CcSEcCtD
Goserelin—Oedema—Prednisolone—atopic dermatitis	0.000324	0.000427	CcSEcCtD
Goserelin—Vomiting—Tacrolimus—atopic dermatitis	0.000322	0.000425	CcSEcCtD
Goserelin—Rash—Tacrolimus—atopic dermatitis	0.00032	0.000422	CcSEcCtD
Goserelin—Dermatitis—Tacrolimus—atopic dermatitis	0.000319	0.000421	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCL10—atopic dermatitis	0.000319	0.00132	CbGpPWpGaD
Goserelin—Shock—Prednisolone—atopic dermatitis	0.000319	0.00042	CcSEcCtD
Goserelin—Cough—Triamcinolone—atopic dermatitis	0.000318	0.00042	CcSEcCtD
Goserelin—Headache—Tacrolimus—atopic dermatitis	0.000318	0.000419	CcSEcCtD
Goserelin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000316	0.000417	CcSEcCtD
Goserelin—Oedema—Hydrocortisone—atopic dermatitis	0.000316	0.000417	CcSEcCtD
Goserelin—Convulsion—Triamcinolone—atopic dermatitis	0.000316	0.000417	CcSEcCtD
Goserelin—Tachycardia—Prednisolone—atopic dermatitis	0.000316	0.000417	CcSEcCtD
Goserelin—Convulsion—Methylprednisolone—atopic dermatitis	0.000315	0.000416	CcSEcCtD
Goserelin—Hypertension—Triamcinolone—atopic dermatitis	0.000315	0.000416	CcSEcCtD
Goserelin—Hypertension—Methylprednisolone—atopic dermatitis	0.000314	0.000415	CcSEcCtD
Goserelin—Infection—Hydrocortisone—atopic dermatitis	0.000314	0.000415	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—NFKBIA—atopic dermatitis	0.000313	0.0013	CbGpPWpGaD
Goserelin—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000313	0.000413	CcSEcCtD
Goserelin—Shock—Hydrocortisone—atopic dermatitis	0.000311	0.000411	CcSEcCtD
Goserelin—Myalgia—Triamcinolone—atopic dermatitis	0.000311	0.00041	CcSEcCtD
Goserelin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00031	0.000409	CcSEcCtD
Goserelin—Arthralgia—Methylprednisolone—atopic dermatitis	0.00031	0.000409	CcSEcCtD
Goserelin—Myalgia—Methylprednisolone—atopic dermatitis	0.00031	0.000409	CcSEcCtD
Goserelin—Eye disorder—Prednisone—atopic dermatitis	0.00031	0.000408	CcSEcCtD
Goserelin—Anxiety—Methylprednisolone—atopic dermatitis	0.000309	0.000408	CcSEcCtD
Goserelin—Tachycardia—Hydrocortisone—atopic dermatitis	0.000309	0.000407	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000308	0.000406	CcSEcCtD
Goserelin—Skin disorder—Hydrocortisone—atopic dermatitis	0.000307	0.000405	CcSEcCtD
Goserelin—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000307	0.000405	CcSEcCtD
Goserelin—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000307	0.000405	CcSEcCtD
Goserelin—Discomfort—Triamcinolone—atopic dermatitis	0.000307	0.000405	CcSEcCtD
Goserelin—Discomfort—Methylprednisolone—atopic dermatitis	0.000306	0.000404	CcSEcCtD
Goserelin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000306	0.000403	CcSEcCtD
Goserelin—Dry mouth—Triamcinolone—atopic dermatitis	0.000304	0.000401	CcSEcCtD
Goserelin—Anorexia—Hydrocortisone—atopic dermatitis	0.000301	0.000398	CcSEcCtD
Goserelin—Nausea—Tacrolimus—atopic dermatitis	0.000301	0.000397	CcSEcCtD
Goserelin—Angiopathy—Prednisone—atopic dermatitis	0.0003	0.000396	CcSEcCtD
Goserelin—Confusional state—Methylprednisolone—atopic dermatitis	0.0003	0.000395	CcSEcCtD
Goserelin—Immune system disorder—Prednisone—atopic dermatitis	0.000299	0.000395	CcSEcCtD
Goserelin—Malaise—Betamethasone—atopic dermatitis	0.000299	0.000394	CcSEcCtD
Goserelin—Malaise—Dexamethasone—atopic dermatitis	0.000299	0.000394	CcSEcCtD
Goserelin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000298	0.000393	CcSEcCtD
Goserelin—Oedema—Triamcinolone—atopic dermatitis	0.000298	0.000393	CcSEcCtD
Goserelin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000297	0.000392	CcSEcCtD
Goserelin—Arrhythmia—Prednisone—atopic dermatitis	0.000296	0.00039	CcSEcCtD
Goserelin—Infection—Triamcinolone—atopic dermatitis	0.000296	0.00039	CcSEcCtD
Goserelin—Hypotension—Hydrocortisone—atopic dermatitis	0.000296	0.00039	CcSEcCtD
Goserelin—Infection—Methylprednisolone—atopic dermatitis	0.000295	0.000389	CcSEcCtD
Goserelin—Shock—Triamcinolone—atopic dermatitis	0.000293	0.000387	CcSEcCtD
Goserelin—Insomnia—Prednisolone—atopic dermatitis	0.000293	0.000386	CcSEcCtD
Goserelin—Alopecia—Prednisone—atopic dermatitis	0.000293	0.000386	CcSEcCtD
Goserelin—Shock—Methylprednisolone—atopic dermatitis	0.000292	0.000386	CcSEcCtD
Goserelin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000291	0.000384	CcSEcCtD
Goserelin—Paraesthesia—Prednisolone—atopic dermatitis	0.000291	0.000384	CcSEcCtD
Goserelin—Tachycardia—Triamcinolone—atopic dermatitis	0.000291	0.000383	CcSEcCtD
Goserelin—Mental disorder—Prednisone—atopic dermatitis	0.00029	0.000383	CcSEcCtD
Goserelin—Tachycardia—Methylprednisolone—atopic dermatitis	0.00029	0.000383	CcSEcCtD
Goserelin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000289	0.000381	CcSEcCtD
Goserelin—Malnutrition—Prednisone—atopic dermatitis	0.000288	0.00038	CcSEcCtD
Goserelin—Erythema—Prednisone—atopic dermatitis	0.000288	0.00038	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000288	0.00038	CcSEcCtD
Goserelin—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000288	0.00038	CcSEcCtD
Goserelin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000287	0.000379	CcSEcCtD
Goserelin—Convulsion—Dexamethasone—atopic dermatitis	0.000287	0.000378	CcSEcCtD
Goserelin—Convulsion—Betamethasone—atopic dermatitis	0.000287	0.000378	CcSEcCtD
Goserelin—Insomnia—Hydrocortisone—atopic dermatitis	0.000286	0.000377	CcSEcCtD
Goserelin—Hypertension—Betamethasone—atopic dermatitis	0.000286	0.000377	CcSEcCtD
Goserelin—Hypertension—Dexamethasone—atopic dermatitis	0.000286	0.000377	CcSEcCtD
Goserelin—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000284	0.000375	CcSEcCtD
Goserelin—Myalgia—Betamethasone—atopic dermatitis	0.000282	0.000372	CcSEcCtD
Goserelin—Myalgia—Dexamethasone—atopic dermatitis	0.000282	0.000372	CcSEcCtD
Goserelin—Anxiety—Betamethasone—atopic dermatitis	0.000281	0.000371	CcSEcCtD
Goserelin—Anxiety—Dexamethasone—atopic dermatitis	0.000281	0.000371	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000279	0.00116	CbGpPWpGaD
Goserelin—Discomfort—Betamethasone—atopic dermatitis	0.000278	0.000367	CcSEcCtD
Goserelin—Discomfort—Dexamethasone—atopic dermatitis	0.000278	0.000367	CcSEcCtD
Goserelin—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000278	0.000367	CcSEcCtD
Goserelin—Hypotension—Methylprednisolone—atopic dermatitis	0.000278	0.000366	CcSEcCtD
Goserelin—Pain—Prednisolone—atopic dermatitis	0.000277	0.000365	CcSEcCtD
Goserelin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000275	0.000363	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCL5—atopic dermatitis	0.000274	0.00114	CbGpPWpGaD
Goserelin—Fatigue—Hydrocortisone—atopic dermatitis	0.000273	0.00036	CcSEcCtD
Goserelin—Vision blurred—Prednisone—atopic dermatitis	0.000272	0.000359	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000271	0.000358	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000271	0.000357	CcSEcCtD
Goserelin—Pain—Hydrocortisone—atopic dermatitis	0.00027	0.000357	CcSEcCtD
Goserelin—Oedema—Betamethasone—atopic dermatitis	0.00027	0.000357	CcSEcCtD
Goserelin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.00027	0.000357	CcSEcCtD
Goserelin—Oedema—Dexamethasone—atopic dermatitis	0.00027	0.000357	CcSEcCtD
Goserelin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.00027	0.000357	CcSEcCtD
Goserelin—Insomnia—Triamcinolone—atopic dermatitis	0.000269	0.000355	CcSEcCtD
Goserelin—Insomnia—Methylprednisolone—atopic dermatitis	0.000269	0.000355	CcSEcCtD
Goserelin—Infection—Dexamethasone—atopic dermatitis	0.000268	0.000354	CcSEcCtD
Goserelin—Infection—Betamethasone—atopic dermatitis	0.000268	0.000354	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisone—atopic dermatitis	0.000268	0.000353	CcSEcCtD
Goserelin—Paraesthesia—Triamcinolone—atopic dermatitis	0.000267	0.000353	CcSEcCtD
Goserelin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000267	0.000352	CcSEcCtD
Goserelin—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000267	0.000352	CcSEcCtD
Goserelin—Anaemia—Prednisone—atopic dermatitis	0.000266	0.000352	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—IL2—atopic dermatitis	0.000266	0.0011	CbGpPWpGaD
Goserelin—Shock—Dexamethasone—atopic dermatitis	0.000266	0.000351	CcSEcCtD
Goserelin—Shock—Betamethasone—atopic dermatitis	0.000266	0.000351	CcSEcCtD
Goserelin—Dyspnoea—Triamcinolone—atopic dermatitis	0.000265	0.00035	CcSEcCtD
Goserelin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000265	0.00035	CcSEcCtD
Goserelin—Nervous system disorder—Betamethasone—atopic dermatitis	0.000265	0.00035	CcSEcCtD
Goserelin—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000265	0.000349	CcSEcCtD
Goserelin—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000265	0.000349	CcSEcCtD
Goserelin—Tachycardia—Dexamethasone—atopic dermatitis	0.000264	0.000348	CcSEcCtD
Goserelin—Tachycardia—Betamethasone—atopic dermatitis	0.000264	0.000348	CcSEcCtD
Goserelin—Dyspepsia—Triamcinolone—atopic dermatitis	0.000262	0.000346	CcSEcCtD
Goserelin—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000262	0.000345	CcSEcCtD
Goserelin—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000261	0.000345	CcSEcCtD
Goserelin—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000261	0.000345	CcSEcCtD
Goserelin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000261	0.000344	CcSEcCtD
Goserelin—Malaise—Prednisone—atopic dermatitis	0.00026	0.000343	CcSEcCtD
Goserelin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000259	0.000341	CcSEcCtD
Goserelin—Anorexia—Betamethasone—atopic dermatitis	0.000258	0.00034	CcSEcCtD
Goserelin—Anorexia—Dexamethasone—atopic dermatitis	0.000258	0.00034	CcSEcCtD
Goserelin—Urticaria—Prednisolone—atopic dermatitis	0.000257	0.000339	CcSEcCtD
Goserelin—Fatigue—Triamcinolone—atopic dermatitis	0.000257	0.000339	CcSEcCtD
Goserelin—Fatigue—Methylprednisolone—atopic dermatitis	0.000256	0.000338	CcSEcCtD
Goserelin—Pain—Triamcinolone—atopic dermatitis	0.000255	0.000336	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NGF—atopic dermatitis	0.000254	0.00105	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000253	0.00105	CbGpPWpGaD
Goserelin—Hypotension—Betamethasone—atopic dermatitis	0.000252	0.000333	CcSEcCtD
Goserelin—Hypotension—Dexamethasone—atopic dermatitis	0.000252	0.000333	CcSEcCtD
Goserelin—Urticaria—Hydrocortisone—atopic dermatitis	0.000251	0.000332	CcSEcCtD
Goserelin—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00025	0.00033	CcSEcCtD
Goserelin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00025	0.00033	CcSEcCtD
Goserelin—Convulsion—Prednisone—atopic dermatitis	0.00025	0.00033	CcSEcCtD
Goserelin—Hypertension—Prednisone—atopic dermatitis	0.000249	0.000328	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR5—atopic dermatitis	0.000247	0.00103	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000246	0.000325	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000246	0.000325	CcSEcCtD
Goserelin—Myalgia—Prednisone—atopic dermatitis	0.000245	0.000324	CcSEcCtD
Goserelin—Arthralgia—Prednisone—atopic dermatitis	0.000245	0.000324	CcSEcCtD
Goserelin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000245	0.000324	CcSEcCtD
Goserelin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000245	0.000323	CcSEcCtD
Goserelin—Anxiety—Prednisone—atopic dermatitis	0.000245	0.000323	CcSEcCtD
Goserelin—Insomnia—Dexamethasone—atopic dermatitis	0.000244	0.000322	CcSEcCtD
Goserelin—Insomnia—Betamethasone—atopic dermatitis	0.000244	0.000322	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000244	0.000322	CcSEcCtD
Goserelin—GNRHR—head—atopic dermatitis	0.000243	0.214	CbGeAlD
Goserelin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000243	0.000321	CcSEcCtD
Goserelin—Paraesthesia—Dexamethasone—atopic dermatitis	0.000243	0.00032	CcSEcCtD
Goserelin—Paraesthesia—Betamethasone—atopic dermatitis	0.000243	0.00032	CcSEcCtD
Goserelin—Discomfort—Prednisone—atopic dermatitis	0.000243	0.00032	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL2—atopic dermatitis	0.000242	0.001	CbGpPWpGaD
Goserelin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000239	0.000315	CcSEcCtD
Goserelin—Dyspepsia—Betamethasone—atopic dermatitis	0.000238	0.000314	CcSEcCtD
Goserelin—Dyspepsia—Dexamethasone—atopic dermatitis	0.000238	0.000314	CcSEcCtD
Goserelin—Urticaria—Triamcinolone—atopic dermatitis	0.000237	0.000312	CcSEcCtD
Goserelin—Urticaria—Methylprednisolone—atopic dermatitis	0.000236	0.000311	CcSEcCtD
Goserelin—Body temperature increased—Triamcinolone—atopic dermatitis	0.000235	0.000311	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000235	0.00031	CcSEcCtD
Goserelin—Oedema—Prednisone—atopic dermatitis	0.000235	0.00031	CcSEcCtD
Goserelin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000235	0.00031	CcSEcCtD
Goserelin—Decreased appetite—Betamethasone—atopic dermatitis	0.000235	0.00031	CcSEcCtD
Goserelin—Decreased appetite—Dexamethasone—atopic dermatitis	0.000235	0.00031	CcSEcCtD
Goserelin—Infection—Prednisone—atopic dermatitis	0.000234	0.000308	CcSEcCtD
Goserelin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000233	0.000307	CcSEcCtD
Goserelin—Fatigue—Betamethasone—atopic dermatitis	0.000233	0.000307	CcSEcCtD
Goserelin—Fatigue—Dexamethasone—atopic dermatitis	0.000233	0.000307	CcSEcCtD
Goserelin—Shock—Prednisone—atopic dermatitis	0.000232	0.000305	CcSEcCtD
Goserelin—Pain—Betamethasone—atopic dermatitis	0.000231	0.000305	CcSEcCtD
Goserelin—Pain—Dexamethasone—atopic dermatitis	0.000231	0.000305	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—atopic dermatitis	0.000231	0.000304	CcSEcCtD
Goserelin—Tachycardia—Prednisone—atopic dermatitis	0.00023	0.000303	CcSEcCtD
Goserelin—Skin disorder—Prednisone—atopic dermatitis	0.000229	0.000302	CcSEcCtD
Goserelin—Hyperhidrosis—Prednisone—atopic dermatitis	0.000227	0.0003	CcSEcCtD
Goserelin—Asthenia—Hydrocortisone—atopic dermatitis	0.000227	0.000299	CcSEcCtD
Goserelin—Anorexia—Prednisone—atopic dermatitis	0.000224	0.000296	CcSEcCtD
Goserelin—Pruritus—Hydrocortisone—atopic dermatitis	0.000224	0.000295	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CXCL8—atopic dermatitis	0.000223	0.000926	CbGpPWpGaD
Goserelin—Feeling abnormal—Betamethasone—atopic dermatitis	0.000223	0.000294	CcSEcCtD
Goserelin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000223	0.000294	CcSEcCtD
Goserelin—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000221	0.000292	CcSEcCtD
Goserelin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000221	0.000292	CcSEcCtD
Goserelin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000219	0.000289	CcSEcCtD
Goserelin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000219	0.000289	CcSEcCtD
Goserelin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000216	0.000286	CcSEcCtD
Goserelin—Urticaria—Dexamethasone—atopic dermatitis	0.000215	0.000283	CcSEcCtD
Goserelin—Urticaria—Betamethasone—atopic dermatitis	0.000215	0.000283	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000214	0.000283	CcSEcCtD
Goserelin—Dizziness—Prednisolone—atopic dermatitis	0.000214	0.000283	CcSEcCtD
Goserelin—Asthenia—Triamcinolone—atopic dermatitis	0.000214	0.000282	CcSEcCtD
Goserelin—Abdominal pain—Betamethasone—atopic dermatitis	0.000214	0.000282	CcSEcCtD
Goserelin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000214	0.000282	CcSEcCtD
Goserelin—Body temperature increased—Dexamethasone—atopic dermatitis	0.000214	0.000282	CcSEcCtD
Goserelin—Body temperature increased—Betamethasone—atopic dermatitis	0.000214	0.000282	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IL2—atopic dermatitis	0.000213	0.000885	CbGpPWpGaD
Goserelin—Asthenia—Methylprednisolone—atopic dermatitis	0.000213	0.000281	CcSEcCtD
Goserelin—Insomnia—Prednisone—atopic dermatitis	0.000213	0.000281	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL6—atopic dermatitis	0.000212	0.000881	CbGpPWpGaD
Goserelin—Paraesthesia—Prednisone—atopic dermatitis	0.000211	0.000279	CcSEcCtD
Goserelin—Pruritus—Triamcinolone—atopic dermatitis	0.000211	0.000278	CcSEcCtD
Goserelin—Pruritus—Methylprednisolone—atopic dermatitis	0.00021	0.000277	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—NFKBIA—atopic dermatitis	0.00021	0.00087	CbGpPWpGaD
Goserelin—Dizziness—Hydrocortisone—atopic dermatitis	0.000209	0.000276	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—atopic dermatitis	0.000207	0.000273	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—atopic dermatitis	0.000205	0.00027	CcSEcCtD
Goserelin—Rash—Prednisolone—atopic dermatitis	0.000204	0.000269	CcSEcCtD
Goserelin—Dermatitis—Prednisolone—atopic dermatitis	0.000204	0.000269	CcSEcCtD
Goserelin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000203	0.000268	CcSEcCtD
Goserelin—Fatigue—Prednisone—atopic dermatitis	0.000203	0.000268	CcSEcCtD
Goserelin—Headache—Prednisolone—atopic dermatitis	0.000203	0.000268	CcSEcCtD
Goserelin—Constipation—Prednisone—atopic dermatitis	0.000201	0.000266	CcSEcCtD
Goserelin—Vomiting—Hydrocortisone—atopic dermatitis	0.000201	0.000265	CcSEcCtD
Goserelin—Rash—Hydrocortisone—atopic dermatitis	0.000199	0.000263	CcSEcCtD
Goserelin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000199	0.000263	CcSEcCtD
Goserelin—Headache—Hydrocortisone—atopic dermatitis	0.000198	0.000261	CcSEcCtD
Goserelin—Dizziness—Triamcinolone—atopic dermatitis	0.000197	0.00026	CcSEcCtD
Goserelin—Dizziness—Methylprednisolone—atopic dermatitis	0.000196	0.000259	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MAPK8—atopic dermatitis	0.000196	0.000815	CbGpPWpGaD
Goserelin—Feeling abnormal—Prednisone—atopic dermatitis	0.000194	0.000256	CcSEcCtD
Goserelin—Asthenia—Betamethasone—atopic dermatitis	0.000194	0.000256	CcSEcCtD
Goserelin—Asthenia—Dexamethasone—atopic dermatitis	0.000194	0.000256	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000192	0.000254	CcSEcCtD
Goserelin—Nausea—Prednisolone—atopic dermatitis	0.000192	0.000254	CcSEcCtD
Goserelin—Pruritus—Dexamethasone—atopic dermatitis	0.000191	0.000252	CcSEcCtD
Goserelin—Pruritus—Betamethasone—atopic dermatitis	0.000191	0.000252	CcSEcCtD
Goserelin—Vomiting—Triamcinolone—atopic dermatitis	0.000189	0.00025	CcSEcCtD
Goserelin—Vomiting—Methylprednisolone—atopic dermatitis	0.000189	0.000249	CcSEcCtD
Goserelin—Nausea—Hydrocortisone—atopic dermatitis	0.000188	0.000248	CcSEcCtD
Goserelin—Rash—Triamcinolone—atopic dermatitis	0.000188	0.000248	CcSEcCtD
Goserelin—Dermatitis—Triamcinolone—atopic dermatitis	0.000188	0.000248	CcSEcCtD
Goserelin—Rash—Methylprednisolone—atopic dermatitis	0.000187	0.000247	CcSEcCtD
Goserelin—Dermatitis—Methylprednisolone—atopic dermatitis	0.000187	0.000247	CcSEcCtD
Goserelin—Urticaria—Prednisone—atopic dermatitis	0.000187	0.000247	CcSEcCtD
Goserelin—Headache—Triamcinolone—atopic dermatitis	0.000187	0.000246	CcSEcCtD
Goserelin—Headache—Methylprednisolone—atopic dermatitis	0.000186	0.000246	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—atopic dermatitis	0.000186	0.000245	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—atopic dermatitis	0.000186	0.000245	CcSEcCtD
Goserelin—Diarrhoea—Betamethasone—atopic dermatitis	0.000185	0.000244	CcSEcCtD
Goserelin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000185	0.000244	CcSEcCtD
Goserelin—Dizziness—Dexamethasone—atopic dermatitis	0.000179	0.000236	CcSEcCtD
Goserelin—Dizziness—Betamethasone—atopic dermatitis	0.000179	0.000236	CcSEcCtD
Goserelin—Nausea—Triamcinolone—atopic dermatitis	0.000177	0.000233	CcSEcCtD
Goserelin—Nausea—Methylprednisolone—atopic dermatitis	0.000176	0.000233	CcSEcCtD
Goserelin—Hypersensitivity—Prednisone—atopic dermatitis	0.000173	0.000229	CcSEcCtD
Goserelin—Vomiting—Betamethasone—atopic dermatitis	0.000172	0.000227	CcSEcCtD
Goserelin—Vomiting—Dexamethasone—atopic dermatitis	0.000172	0.000227	CcSEcCtD
Goserelin—Rash—Dexamethasone—atopic dermatitis	0.00017	0.000225	CcSEcCtD
Goserelin—Rash—Betamethasone—atopic dermatitis	0.00017	0.000225	CcSEcCtD
Goserelin—Dermatitis—Betamethasone—atopic dermatitis	0.00017	0.000225	CcSEcCtD
Goserelin—Dermatitis—Dexamethasone—atopic dermatitis	0.00017	0.000225	CcSEcCtD
Goserelin—Headache—Dexamethasone—atopic dermatitis	0.000169	0.000223	CcSEcCtD
Goserelin—Headache—Betamethasone—atopic dermatitis	0.000169	0.000223	CcSEcCtD
Goserelin—Asthenia—Prednisone—atopic dermatitis	0.000169	0.000223	CcSEcCtD
Goserelin—Pruritus—Prednisone—atopic dermatitis	0.000166	0.00022	CcSEcCtD
Goserelin—Diarrhoea—Prednisone—atopic dermatitis	0.000161	0.000212	CcSEcCtD
Goserelin—Nausea—Betamethasone—atopic dermatitis	0.00016	0.000212	CcSEcCtD
Goserelin—Nausea—Dexamethasone—atopic dermatitis	0.00016	0.000212	CcSEcCtD
Goserelin—Dizziness—Prednisone—atopic dermatitis	0.000156	0.000205	CcSEcCtD
Goserelin—Vomiting—Prednisone—atopic dermatitis	0.00015	0.000197	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCL8—atopic dermatitis	0.000149	0.00062	CbGpPWpGaD
Goserelin—Rash—Prednisone—atopic dermatitis	0.000148	0.000196	CcSEcCtD
Goserelin—Dermatitis—Prednisone—atopic dermatitis	0.000148	0.000196	CcSEcCtD
Goserelin—Headache—Prednisone—atopic dermatitis	0.000147	0.000195	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IL2—atopic dermatitis	0.000143	0.000593	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—atopic dermatitis	0.000142	0.00059	CbGpPWpGaD
Goserelin—Nausea—Prednisone—atopic dermatitis	0.00014	0.000184	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—MAPK8—atopic dermatitis	0.000131	0.000546	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—atopic dermatitis	0.000125	0.00052	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—atopic dermatitis	8.4e-05	0.000348	CbGpPWpGaD
